(S)-5-Methyl-1-(2-(pyridin-3-yl)ethyl)imidazolidin-2-imine

ID: ALA4084577

PubChem CID: 132493986

Max Phase: Preclinical

Molecular Formula: C11H16N4

Molecular Weight: 204.28

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@H]1CNC(=N)N1CCc1cccnc1

Standard InChI:  InChI=1S/C11H16N4/c1-9-7-14-11(12)15(9)6-4-10-3-2-5-13-8-10/h2-3,5,8-9H,4,6-7H2,1H3,(H2,12,14)/t9-/m0/s1

Standard InChI Key:  GIQJQATVWVFAFP-VIFPVBQESA-N

Molfile:  

     RDKit          2D

 15 16  0  0  0  0  0  0  0  0999 V2000
    2.5960  -10.2273    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4132  -10.2273    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6676   -9.4506    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0046   -8.9685    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3459   -9.4506    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0033   -8.1513    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4451   -9.1991    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6161   -8.4001    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3937   -8.1486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9985   -8.6976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7754   -8.4467    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9470   -7.6468    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3356   -7.0983    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.5610   -7.3521    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8927  -10.8890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  1  1  0
  4  6  2  0
  3  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
  2 15  1  1
M  END

Alternative Forms

  1. Parent:

    ALA4084577

    ---

Associated Targets(Human)

CHRNA7 Tchem Neuronal acetylcholine receptor protein alpha-7 subunit (3524 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Chrna3 Neuronal acetylcholine receptor; alpha3/beta4 (1368 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Chrna4 Neuronal acetylcholine receptor; alpha4/beta4 (595 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Chrna4 Neuronal acetylcholine receptor; alpha4/beta2 (3557 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Chrna3 NIcotinic acetylcholine receptor alpha-3/beta-4/alpha-5 (2 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Chrna3 Neuronal acetylcholine receptor; alpha3/beta2 (421 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Blood (1237 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Brain (4256 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 204.28Molecular Weight (Monoisotopic): 204.1375AlogP: 0.85#Rotatable Bonds: 3
Polar Surface Area: 52.01Molecular Species: BASEHBA: 2HBD: 2
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 12.07CX LogP: 0.62CX LogD: -1.79
Aromatic Rings: 1Heavy Atoms: 15QED Weighted: 0.77Np Likeness Score: -0.57

References

1. Wu J, Cippitelli A, Zhang Y, Debevec G, Schoch J, Ozawa A, Yu Y, Liu H, Chen W, Houghten RA, Welmaker GS, Giulianotti MA, Toll L..  (2017)  Highly Selective and Potent α4β2 nAChR Antagonist Inhibits Nicotine Self-Administration and Reinstatement in Rats.,  60  (24): [PMID:29178785] [10.1021/acs.jmedchem.7b01250]

Source